← All Industries
🏥
Healthcare
22 companies · Peer comparison
| Company | Score | GM | ROE | CF/NI | FCF | GW/A |
|---|---|---|---|---|---|---|
| ISRGINTUITIVE SURGICAL INC2025 | B87 | 66.0% | 16.0% | 1.06x | $2.5B | 1.8% |
| GILDGilead Sciences2025 | B86 | 78.8% | 37.5% | 1.18x | $9.5B | 14.1% |
| IDXXIDEXX Laboratories2025 | B85 | 61.8% | 66.0% | 1.12x | $1.1B | 12.4% |
| VRTXVERTEX PHARMACEUTICALS INC2025 | B83 | 86.2% | 21.2% | 0.92x | $3.2B | 4.2% |
| REGNREGENERON PHARMACEUTICALS INC2025 | B81 | 100.0% | 14.4% | 1.11x | $4.1B | — |
| TMOTHERMO FISHER SCIENTIFIC INC.2025 | C76 | 100.0% | 12.6% | 1.17x | $6.3B | 44.7% |
| ABTABBOTT LABORATORIES2025 | C76 | 56.4% | 12.5% | 1.47x | $7.4B | 27.7% |
| DXCMDexCom2025 | C76 | 60.1% | 30.5% | 1.72x | $1.1B | 0.4% |
| SYKSTRYKER CORP2025 | C75 | 64.5% | — | 5.94x | $4.3B | 40.3% |
| UNHUNITEDHEALTH GROUP INCORPORATED2025 | C73 | 88.7% | — | 1.63x | $16.1B | 35.7% |
| LLYELI LILLY AND COMPANY2025 | C71 | 83.0% | 77.8% | 0.81x | $16.8B | 5.2% |
| AMGNAMGEN INC2025 | C71 | 67.2% | 89.1% | 1.29x | $8.1B | 20.6% |
| JNJJohnson & Johnson2025 | C70 | 67.9% | — | 0.92x | $19.7B | 24.5% |
| BMYBRISTOL-MYERS SQUIBB COMPANY2025 | C70 | 71.1% | 38.2% | 2.01x | $12.8B | 24.2% |
| ILMNIllumina2025 | D68 | 66.1% | 31.2% | 1.27x | $931M | 16.8% |
| PFEPFIZER INC2025 | D65 | 74.3% | 9.0% | 1.51x | $9.1B | 34.2% |
| DHRDANAHER CORPORATION2025 | D65 | 59.1% | 6.9% | 1.78x | $5.3B | 51.7% |
| MRKMerck & Co., Inc.2025 | D64 | 74.8% | 34.7% | 0.90x | $12.4B | 15.8% |
| ABBVABBVIE INC.2025 | D64 | 72.6% | -55.5% | 10.48x | $17.8B | 26.6% |
| BIIBBiogen2025 | F52 | 75.7% | — | 1.71x | $2.1B | 22.0% |
| GEHCGE HealthCare2025 | F44 | 40.0% | 20.1% | — | $-482M | 36.5% |
| MRNAModerna2025 | F25 | 55.3% | -32.6% | 0.66x | $-2.1B | 0.4% |
Strong Moderate WeakGM = Gross Margin · ROE = Return on Equity · CF/NI = Cash Flow/Net Income · FCF = Free Cash Flow · GW/A = Goodwill/Assets